INTRODUCTION: The ovarian hyperstimulation syndrome (OHSS) is a marked response to ovarian stimulation therapy, triggered by the administration of human chorionic gonadotropin (hCG), which induces the overproduction of vascular endothelial growth factor, resulting in a widespread increase in capillary permeability. Here, VEGFA is linked to ovarian hyperstimulation syndrome.